Ascentage Pharma to start leukaemia therapy trial in US and China

Ascentage Pharma received clearance from the US and Chinese regulatory bodies to conduct the trial for leukaemia. Credit: Credit: Darryl Leja, National Human Genome Research Institute, NIH.